Targeting bacterial kinases as a strategy to counteract antibiotic resistance

Antibiotic resistance is rapidly emerging as one of the most critical health threats, with resistant microorganisms progressively diminishing the effectiveness of established antibiotics. As a result, the development of therapeutic approaches that effectively target resistant pathogens is of utmost importance. In this study, we developed inhibitors for APH(2")-IVa, a bacterial kinase conveying resistance to aminoglycoside antibiotics. Starting from a hit of a fragment-based screening, we explored the inhibitory motif by structure-based design, ultimately leading to a series of triazole analogues. Advanced analogues displayed promising ADME properties, emerging selectivity vs a panel of human kinases, permeability in both Gram-positive and Gram-negative bacteria, and a moderate antibiotic efficacy for clinical strains of P. aeruginosa. Taken together, our results suggest inhibition of bacterial kinases could be a promising option to reinstall the efficacy of aminoglycoside antibiotics.

Authors

Institutions

Publication Details

Journal
Communications Chemistry
Published
2025-12-04
DOI
https://doi.org/10.1038/s42004-025-01794-7
Citations
1
Primary Topic
Bacterial Genetics and Biotechnology
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting bacterial kinases as a strategy to counteract antibiotic resistance

Stefan Knapp, Julien Kowalewski, Catherine Dunyach‐Remy, Katharina Rox et al.
1 citations
Communications Chemistry
Bacterial Genetics and Biotechnology
1.82
article

Targeting bacterial kinases as a strategy to counteract antibiotic resistance

Stefan Knapp, Julien Kowalewski, Catherine Dunyach‐Remy, Katharina Rox, Jean‐François Guichou, Felix Hausch, Vanessa Buffa, Corinne Lionne, Andreas Krämer, Robin C. E. Deutscher, Mathilde Tomaszczyk, Matijas Cica, G.-M. Qi, Marion Richardoz
article en
1 citations

Abstract

Antibiotic resistance is rapidly emerging as one of the most critical health threats, with resistant microorganisms progressively diminishing the effectiveness of established antibiotics. As a result, the development of therapeutic approaches that effectively target resistant pathogens is of utmost importance. In this study, we developed inhibitors for APH(2")-IVa, a bacterial kinase conveying resistance to aminoglycoside antibiotics. Starting from a hit of a fragment-based screening, we explored the inhibitory motif by structure-based design, ultimately leading to a series of triazole analogues. Advanced analogues displayed promising ADME properties, emerging selectivity vs a panel of human kinases, permeability in both Gram-positive and Gram-negative bacteria, and a moderate antibiotic efficacy for clinical strains of P. aeruginosa. Taken together, our results suggest inhibition of bacterial kinases could be a promising option to reinstall the efficacy of aminoglycoside antibiotics.

Communications ChemistryVol. 8(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Structural Genomics Consortium (CA), Technische Universität Darmstadt (DE), Centre de Biologie Structurale (FR), German Center for Infection Research (DE), Helmholtz Centre for Infection Research (DE), Université de Nîmes (FR)
Deutsches Zentrum für Infektionsforschung, Agence Nationale de la Recherche, Bundesministerium für Bildung und Forschung, Mitacs, Association Vaincre la Mucoviscidose, French Infrastructure for Integrated Structural Biology
Openalex Percentile: Top 11%
Bacterial Genetics and Biotechnology
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.